Skip to main content

Spectrum: Autism Research News

Vanessa McKeown

Measuring the outcome of clinical trials

by  /  15 February 2017

Featured Articles

Several arrows have fallen short of their target, which is a pill on a bullseye. This image suggests that a drug targeted towards autism's symptoms has not yet been made.

Why don’t we have better drugs for autism?

by  /  15 February 2017

Clinical trials for autism drugs have been plagued with problems: bad design, the wrong measures, too broad a range of participants. All that is finally starting to change.

Questions for Gahan Pandina: New tool may aid autism trials

by  /  14 February 2017

A new ‘knowledge engine’ collects reams of behavioral and sensory data to create highly sensitive outcome measures for autism drugs.

Despite setbacks, fragile X drugs file into clinical trials

by  /  30 November 2016

Our infographic displays efforts to develop treatments for fragile X syndrome. So far, none of them have passed muster in clinical trials.

From The Archives

Someone writes descriptions on gridded paper, the paper is in the shape of a child's silhouette.
A pill opens up to reveal a puff of smoke, suggesting that pharmaceuticals aren't offering much as promised.
Young girl reading a book
TAGS:   autism